Clinical trial · no report yet · Phase 3
NCT05236946
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
- NCT05236946 ↗
- Recruiting
- Tata Memorial Hospital
- 3 commentary sources found
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built. Commentary is thin so far, so the report would be short.
| Channel | Found | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- Observation or Upfront Cranial RT in Oncogene Driver Mutated NSCLC With Asymptomatic Brain Metastases: A Phase III Randomized Controlled Trial
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Asymptomatic Brain Metastases; Driver Mutation Positive Non-small Cell Lung Cancer
- Interventions
- Stereotactic radiosurgery/whole brain radiotherapy; Tyrosine kinase inhibitor
- Arms
- Upfront Cranial Radiotherapy · Active comparator
- Observation (Delayed Cranial Radiotherapy) · Experimental
- Enrollment
- 190 (estimated)
- Primary outcomes
- Intracranial progression free survival at 24 months
- Sponsor
- Tata Memorial Hospital
- Start
- Nov 10, 2020
- Primary completion
- Dec 2025 (estimated)
- Results posted
- No
- Registry record
- NCT05236946 · updated Sep 10, 2025